5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy ; volume:13 ; number:1 ; day:22 ; month:6 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (22.6.2023), 1-11, 12.2023
- Urheber
-
Fukumura, Masao
Nonoguchi, Naosuke
Kawabata, Shinji
Hiramatsu, Ryo
Futamura, Gen
Takeuchi, Koji
Kanemitsu, Takuya
Takata, Takushi
Tanaka, Hiroki
Suzuki, Minoru
Sampetrean, Oltea
Ikeda, Naokado
Kuroiwa, Toshihiko
Saya, Hideyuki
Nakano, Ichiro
Wanibuchi, Masahiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-37296-6
- URN
-
urn:nbn:de:101:1-2023092508443710876586
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fukumura, Masao
- Nonoguchi, Naosuke
- Kawabata, Shinji
- Hiramatsu, Ryo
- Futamura, Gen
- Takeuchi, Koji
- Kanemitsu, Takuya
- Takata, Takushi
- Tanaka, Hiroki
- Suzuki, Minoru
- Sampetrean, Oltea
- Ikeda, Naokado
- Kuroiwa, Toshihiko
- Saya, Hideyuki
- Nakano, Ichiro
- Wanibuchi, Masahiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax
Experimental validation of proton boron capture therapy for glioma cells
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro
Theranostics in Boron Neutron Capture Therapy
Binding distribution and cellular uptake of Na2B12H11SH (BSH) in tumor tissue of glioma patients : investigations for boron neutron capture therapy
Boron-neutron Capture on Activated Carbon for Hydrogen Storage
Boron delivery agents for neutron capture therapy of cancer
Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy
Nanostructured boron agents for boron neutron capture therapy: a review of recent patents
Current development status of accelerator-based neutron source for boron neutron capture therapy
Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax
Experimental validation of proton boron capture therapy for glioma cells
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro
Theranostics in Boron Neutron Capture Therapy
Binding distribution and cellular uptake of Na2B12H11SH (BSH) in tumor tissue of glioma patients : investigations for boron neutron capture therapy
Boron-neutron Capture on Activated Carbon for Hydrogen Storage
Boron delivery agents for neutron capture therapy of cancer
Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy
Nanostructured boron agents for boron neutron capture therapy: a review of recent patents
Current development status of accelerator-based neutron source for boron neutron capture therapy
Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax
Experimental validation of proton boron capture therapy for glioma cells
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro
Theranostics in Boron Neutron Capture Therapy
Binding distribution and cellular uptake of Na2B12H11SH (BSH) in tumor tissue of glioma patients : investigations for boron neutron capture therapy
Boron-neutron Capture on Activated Carbon for Hydrogen Storage
Boron delivery agents for neutron capture therapy of cancer
Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy
Nanostructured boron agents for boron neutron capture therapy: a review of recent patents